Search
Close
Search
Advanced Search
Search Menu
AI Discovery Assistant

Extract

Funding sources: none.

Conflicts of interest: none declared.

Dear Editor, Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a known association with obesity.1 Evidence of an association between metabolic syndrome and HS has been reported.2 The Framingham Risk Score (FRS) is a sex‐specific algorithm used to estimate an individual's 10‐year cardiovascular risk.3 Despite limitations of its use, it remains one of the most widely used risk assessment tools. Patients scoring < 10% are considered to be at low risk, those between 10% and 20% at moderate risk and those scoring ≥ 20% at high risk. We sought to establish FRS in a cohort of patients with HS to provide a different approach to assessing absolute cardiovascular risk, and then to compare these scores with a control group of patients with psoriasis.4

This study was a multicentre, prospective, observational, cohort study. The FRS was calculated for patients aged ≥ 30 years. The findings were compared with FRS in 103 patients with psoriasis, recruited in a prior study. In total, 263 patients with HS were recruited (Table 1). The mean age was 40·6 years (range 16–75), 70% (185) were female and 70% (185) were smokers. Of 103 patients with psoriasis, 52 were men and 51 were women, with a mean age of 40 years (range 21–69) and a mean Psoriasis Area and Severity Index of 9 (range 3–22·8).

Issue Section:
Correspondence > Letters to the Editor
You do not currently have access to this article.
Download all slides